What features should a modern RIM system include? At minimum: a centralized document core, submission building tools aligned to agency structures, project and task tracking, an eCTD viewer, dedicated correspondence and commitment tracking, and a validated, Part 11-compliant audit trail. A system missing any of these leaves a regulatory team re-building the gap in spreadsheets, email threads, or a second tool — exactly the fragmentation a RIM system is supposed to remove.
This isn't an abstract question. The global regulatory information management software market is valued at roughly $2.7 billion in 2026 and is projected to reach $8.1 billion by 2036, a 10.8% CAGR [1] — growth driven in large part by regulatory teams replacing spreadsheets and disconnected tools with purpose-built systems as submission volume and multi-region complexity outgrow what a shared drive can handle. Below is a breakdown of each capability, what "good" looks like in practice, and how a few of the platforms regulatory teams evaluate — including Kivo — approach them.
Table of Contents
- Centralized Document Organization
- Submission Building and Publishing Handoff
- Project and Task Tracking
- eCTD Viewing and Lifecycle Visibility
- Correspondence and Commitment Tracking
- Compliance, Validation, and Audit Trail
- How RIM Platforms Compare on These Features
- How Kivo RIM Approaches These Features
- FAQ
Centralized Document Organization
A RIM system's first job is giving regulatory content one home instead of several. That means controlled documents — from corporate policies to submission materials to agency correspondence — living in a single system with version control, audit trails, and defined review/approval workflows, rather than split across a document management tool, a shared drive, and an inbox.
(For a broader primer on what RIM covers before diving into features specifically, see Kivo's RIM overview.) In practice, this works best when the document structure is modeled on an established framework rather than invented from scratch. The EDM (Electronic Document Management) Reference Model is the most common starting point: it gives regulatory teams a pre-built taxonomy for organizing submission content, correspondence, and supporting documentation so that the same structure holds whether a team is managing one IND or a full portfolio. A system that supports hundreds of pre-formatted templates aligned to ICH, FDA, and other agency formats saves a team from re-creating document shells for every new submission.
Submission Building and Publishing Handoff
A RIM system should let a team assemble submission-ready content against agency-aligned structures, with documents linked directly back to the underlying DMS rather than copied into a separate publishing tool. Look for pre-built submission structures that match agency guidelines, automatic tracking of what's been included in a given submission, and a toggle for blinded versus unblinded data where a program requires it.
Not every RIM system needs to include eCTD publishing itself, and there's a real argument for why it shouldn't: a platform that deliberately stops short of publishing avoids marking up a white-labeled third-party publishing tool and avoids locking a team into one publishing vendor. What matters more is a clean handoff — an automatic tracking spreadsheet and a one-click export of submission-ready documents to whatever internal or external publishing group a team already uses, with the submitted eCTD remaining viewable and linked back to its DMS source afterward.
Project and Task Tracking
A RIM system should let a team templatize regulatory project plans, assign owners and due dates with dependencies built in, and have timelines automatically reflow as upstream dates shift. Regulatory programs run on deadlines that cascade — an agency response window shifts a submission date, which shifts a CMC update, which shifts a labeling review — and a system that can't reflow automatically just means a team manually rebuilding a tracker every time one date changes.
Real-time reporting and scheduled email delivery matter here too. A regulatory lead shouldn't have to log into a system and manually compile status for a portfolio review; the system should be able to push that reporting out on a schedule.
eCTD Viewing and Lifecycle Visibility
An eCTD viewer built into the RIM system — rather than a separate licensed tool — should support current eCTD versions, sequence and cumulative views, inline study tagging, and visibility into the underlying DMS metadata for any viewed document, with submission archiving so sequences stay accessible for the life of the product. Even when publishing itself happens elsewhere, a team still needs to see what's actually been submitted, by sequence, by module, and across the cumulative lifecycle of a dossier.
This capability also needs to reflect where a team actually submits. A system that only supports FDA-format eCTDs is a problem the moment a program goes global — a RIM system worth evaluating should support submission formats accepted across the agencies a sponsor actually works with, not just the one it started with.
Correspondence and Commitment Tracking
A RIM system should capture agency correspondence in whatever form it arrives — email, PDF, scanned letter, call log — and tie it to the project, document, or submission it relates to through smart associations, rather than leaving it to live in someone's inbox. This is the capability that's easiest to underestimate and most costly to do without: every piece of correspondence can carry a commitment with a deadline attached, and a regulatory team that can't track those systematically is managing deadlines by memory.
The stronger version of this capability automates the connection: as expected correspondence arrives, the system updates the relevant submission project automatically, and a team can report on open commitments by agency, by project, or by type at any point — which is the difference between knowing a commitment deadline is coming and finding out about it the week it's due.
Compliance, Validation, and Audit Trail
A RIM system should produce an automatic, uneditable audit trail on every document and record, support role-based per-user licensing (including limited or read-only access types for stakeholders who only need visibility), and include native Part 11-compliant electronic signatures built into the platform itself rather than bolted on through a separate tool. None of the other capabilities above matter if the underlying system can't demonstrate, on inspection, exactly who changed what and when.
Standards alignment matters too, and it's getting more concrete, not less. The EU's ISO IDMP standards — mandated for EU member states, marketing authorization holders, and EMA under Commission Implementing Regulation (EU) No 520/2012 — require standardized identification and description of medicinal products across the full product lifecycle, from development through authorized products, and apply to regulatory submissions, pharmacovigilance reporting, and GMP inspection data alike [2]. Implementation is genuinely uneven across regions: Switzerland has mapped roughly 70% of its approved substances to IDMP standards so far, Canada only established its data governance framework in 2022, and the FDA issued its own ISO IDMP implementation guidance in March 2023 [3]. A RIM system that can't flex to these standards as they mature in whichever markets a sponsor operates in is a system a team will outgrow.
Validation is the other half of this. A RIM system should ship continuous, CSA-aligned validation evidence with every release so a customer's QA team reviews and approves documentation rather than performing the software validation work itself — a meaningful difference from legacy platforms that put that burden entirely on the customer.
How RIM Platforms Compare on These Features
The table below is a general feature comparison across platforms regulatory teams commonly evaluate, based on each vendor's publicly available documentation. It's not an independent ranking, doesn't reflect every configuration a vendor offers, and doesn't assess implementation quality or fit for any particular organization — teams should validate current capabilities directly with each vendor against their own requirements.
| Capability | Kivo RIM | Veeva Vault RIM | Ennov RIM | RegDesk | Rimsys |
|---|---|---|---|---|---|
| Unified document core (shared with DMS/eTMF/QMS) | Yes, native | Shared across Vault apps | Yes, suite-based | Regulatory-focused, narrower scope | Regulatory-focused, narrower scope |
| Built-in eCTD viewer | Yes, included with RIM module | Yes | Yes | Available | Available |
| Dedicated correspondence & commitment tracking | Yes, with automated smart associations | Available | Available | Available | Available |
| Native Part 11 e-signature | Yes, included at no extra charge | Available | Available | Available | Available |
| Typical implementation timeline | Weeks | Not publicly disclosed | Not publicly disclosed | Not publicly disclosed | Not publicly disclosed |
Correspondence and commitment tracking is the one row above where Kivo draws the sharpest contrast: Kivo positions automated, cross-referenced correspondence capture as a direct differentiator against larger, more fragmented category platforms, rather than a bolt-on feature.
How Kivo RIM Approaches These Features
Kivo RIM is built on the EDM Reference Model from the start, with 450+ pre-formatted ICH templates and the document-organization, submission-building, project-tracking, eCTD-viewing, and correspondence-tracking capabilities above all running on the same shared document core as Kivo's DMS, eTMF, and QMS modules — so a regulatory team and the clinical or quality teams around it work from one system instead of stitching four together. Correspondence and commitment tracking in particular is a capability Kivo calls out as a direct differentiator against larger, more fragmented category competitors: correspondence from any source (email, scanned letters, call logs) gets smart-associated to the right project or document automatically, and submission projects update as expected correspondence comes in.
Kivo's RIM module supports IND, CTA, BLA, NDA, ANDA, and CTIS submission types, with eCTD viewing accepted across FDA, EMA, PMDA, Health Canada, Swissmedic, TGA, HSA, and MFDS formats. Every subscription includes Kivo's native, Part 11-compliant electronic signature at no additional charge, and the platform ships continuous CSA-aligned validation evidence with every release. Setup is measured in weeks rather than the six-plus months typical of legacy RIM platforms, and Kivo is currently rated 4.9/5 on G2 — the highest-rated RIM software on the platform.
Frequently Asked Questions
Which RIM system fits small and midsize biotech teams?
Smaller teams generally do better with a RIM system priced and scoped for their size — role-based licensing added in increments of 5 or 10 users, a base package bundling the document core with one module, and setup in weeks, not months. Enterprise-first platforms built for 100+ user organizations often carry overhead that outweighs their depth for a small team.
Which RIM system improves inspection readiness and audit trails?
Look for a RIM system with an automatic, uneditable audit trail on every record by default, rather than one that requires manual logging or a separate audit module. Inspector-specific access that can be granted quickly, showing only finalized (non-draft) versions, is a related capability worth confirming before an inspection is imminent rather than during one.
How to implement a scalable RIM system for biotech?
Implementation typically runs in stages: align on a document structure (often starting from the EDM Reference Model), migrate documents and correspondence with metadata and audit history intact, load validation evidence, then walk through the system before a short training session. A system configurable to existing SOPs, rather than forcing a rebuild around the software, scales better as a team grows.
Do regulatory submission systems need to include eCTD publishing?
Not necessarily. Some platforms deliberately exclude eCTD publishing to avoid marking up a white-labeled third-party tool or locking a sponsor into one publishing vendor, instead preparing submission-ready packages for handoff to a sponsor's chosen publishing partner. What matters more than publishing being in-house is that submitted content stays viewable and linked to its source documents.
Sources: [1] Meticulous Research, Regulatory Information Management Market sizing (2026). [2] European Medicines Agency, "Data on medicines (ISO IDMP standards): Overview". [3] Regulatory Affairs Professionals Society (RAPS), regulators' progress report on IDMP implementation.
